Related Experiment Video
Updated: Aug 11, 2026

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
Published on: March 6, 2014
Posterior Reversible Encephalopathy Syndrome in Early-Stage Breast Cancer
Rahul Ladwa1,2, Geoffrey Peters1,2, Kieron Bigby1,2
1Cancer Care Services, Redcliffe Hospital, Redcliffe, Queensland, Australia.
Abstract:
Wider use of chemotherapy and targeted agents can be associated with posterior reversible encephalopathy syndrome (PRES). This syndrome is most commonly found in metastatic adenocarcinoma treated with platinum-based analogs and is managed with cessation of the precipitating medication. We present the first case of PRES in early-stage breast cancer and discuss the further management of this condition. Recognition of this condition and correction of identifiable precipitating factor including cessation of relevant medications remains important in its management.
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Brain Abscess l: Introduction
Cerebral Edema ll: Pathophysiology
Hepatic Encephalopathy

